🗞️ Story file #1649
FDA requires new eye risk warning on GLP-1 drugs
Nov 9, 5 PM ET to Nov 10, 10 AM ET
- 18outlets carried it
- 🫏9 · 3 · 6🐘left · center · right
- 17 hourson the front pages
- 18front pages at once, at its peak
- 5 minof TV captions
- 4radio newscasts
- 11people retold it online
📰 read it at:
HuffPost
ABC News
AP
CBS News
CNBC
CNN
NBC News
The Independent
The Washington Post
MarketWatch
News Nation
The Hill
Fox Business
The Epoch Times
The Washington Times
New York Post
Newsmax
Townhall
👣 How this story traveled: from the front pages that broke it, out through TV, radio and the shows, into what people retold and what fact-checkers examined, and on into the saga it is part of. Everything here is matched to the story by our tools, so a link can be wrong; the trackers' pages say how each is made.
- Nov 9, 5 PM ETfirst on a front page: ABC News
- Nov 9, 7 PM ETfirst on the radio: NPR News Now
- Nov 9, 8 PM ETfirst on TV: MSNOW
- Nov 10, 5 AM ETretold online by 11 people
- Nov 10, 10 AM ETpeak: on 18 front pages
📰 Spread
the front pages that ran it, hour by hour
📡 Wire copy
1 outlet ran the AP headline nearly word for word
HuffPost
💬 Quoted
- “eye stroke”1
phrases its headlines put in quotation marks; the bar is how many outlets did
📌 Linked by aggregators
2 Drudge Report · Google News
aggregators linking to it from their front page (they don't count as outlets covering it)
✏️ 4 outlets ran more than one headline on it (reworded, or a follow-up)
- ABC News (2 wordings): “FDA orders new warning on GLP-1 drugs over rare eye condition” → “Taking Ozempic or Wegovy? What to know about the FDA's new eye warning”
- Fox Business (2 wordings): “FDA adds rare warning to GLP-1 drugs used by millions” → “FDA adds warning to GLP-1 drugs used by millions over rare risk”
- HuffPost (2 wordings): “FDA Adds Rare Vision-loss Warning To Popular GLP-1 Drugs” → “FDA Adds Rare Vision-Loss Warning To Popular GLP-1 Drugs”
- The Washington Post (2 wordings): “FDA tells GLP-1 makers to warn of potential vision loss side effect” → “FDA tells GLP-1 makers to warn of potential vision loss side effect - The Washington Post”
📰 Every outlet's headline 18left to right by AllSides rating
HuffPost🕒 Nov 9, 10 PM ET
FDA Adds Rare Vision-loss Warning To Popular GLP-1 Drugs
ABC News🕒 Nov 9, 5 PM ET
FDA orders new warning on GLP-1 drugs over rare eye condition
AP🕒 Nov 9, 5 PM ET
FDA adds rare vision-loss warning to popular GLP-1 drugs
CBS News🕒 Nov 9, 8 PM ET
FDA warns of rare vision-loss side effect from GLP-1 drugs
CNBC🕒 Nov 10, 3 AM ET
FDA warns of vision loss risk linked to GLP-1 drugs like Wegovy, Zepbound
CNN🕒 Nov 9, 12 PM ET
US FDA orders new eye risk warnings for Ozempic, Zepbound
NBC News🕒 Nov 9, 2 PM ET
FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
The Independent🕒 Nov 9, 9 PM ET
FDA to require GLP-1 makers to add major change to warning labels
The Washington Post🕒 Nov 9, 5 PM ET
FDA tells GLP-1 makers to warn of potential vision loss side effect
MarketWatch🕒 Nov 9, 1 PM ET
Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss
News Nation🕒 Nov 9, 11 PM ET
FDA requires safety label changes for GLP-1s over risk for eye condition
The Hill🕒 Nov 9, 6 PM ET
FDA warns of rare ‘eye stroke’ risk from GLP-1 drugs
Fox Business🕒 Nov 10, 9 AM ET
FDA adds rare warning to GLP-1 drugs used by millions
The Epoch Times🕒 Nov 9, 4 PM ET
FDA Mandates New Eye Risk Warning on GLP-1 Drugs
The Washington Times🕒 Nov 10, 10 AM ET
FDA warning: Ozempic, other weight-loss drugs can cause vision loss
New York Post🕒 Nov 9, 4 PM ET
GLP-1 drugs must have new warning label over incurable blindness condition, says FDA
Newsmax🕒 Nov 9, 3 PM ET
FDA Orders New Eye Risk Warnings for GLP-1s
Townhall🕒 Nov 9, 8 PM ET
FDA Now Requiring GLP-1 Makers to Warn About Rare but Severe Eye Condition
📡 Broadcast
TV, radio, and the shows that talked about it
- left
- leans left
- right
📺 On TV
minutes its captions were on screen, by channel; the disc is the network's lean
📻 On the radio
hourly newscasts that carried it, by show; beside the count, how often it was the lead story, or the highest it came in the running order
🎙️ On the shows
podcasts, newsletters and streams that talked about it, by show; the bar is episodes; the disc is the show's lean by reputation
🕵️ Investigated, joked about
🕵️ investigative reporting on it and 🃏 satire joking about it (jokes, never counted as coverage); the bar is pieces
🕵️🤷 No investigator or satirist matched to it yet.
🧶 Retelling
what people online made of it
🧶 Retold online
- The FDA is requiring GLP-1 drugs to carry warnings about a rare risk of permanent vision loss. Nov 10: told by 11 people
On Folklore: the latest in full, with their motifs and who is telling them.
FDAGLP-1 drugsOzempicZepbound
🔎 Checking
what the fact-checkers looked into
🧐 No fact-checker has taken it on yet.
🧵 Persistence
the running story it belongs to
🌱 A story of its own so far: no saga yet.